MDHIGH SIGNALFINANCIAL10-K

MEDNAX achieved a dramatic operational turnaround with operating income swinging from -$68.7M to +$208.8M while simultaneously executing significant capital returns through $86.7M in share buybacks.

This represents a fundamental business transformation, moving from operating losses to strong profitability in just one year, suggesting successful execution of a restructuring or cost management strategy. The massive increase in share buybacks signals management confidence in the turnaround's sustainability and commitment to returning excess cash to shareholders.

Comparing 2026-02-19 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

The company delivered exceptional financial performance with operating cash flow growing 31% to $271M and operating income improving by over $277M to reach profitability of $208.8M. Cash position strengthened significantly to $375M while accounts receivable declined 12%, indicating improved collections efficiency. The dramatic increase in share buybacks from $1.7M to $86.7M, combined with strong cash generation and improved working capital management, signals a company that has successfully navigated through previous challenges and is now generating substantial excess cash for shareholder returns.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+4990%
$1.7M→$86.7M

Share repurchases increased 4990% — management returning capital, signals confidence in intrinsic value.

Operating Income
P&L
+403.9%
-$68.7M→$208.8M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+266.9%
-$99.1M→$165.4M

Net income grew 266.9% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+63.2%
$229.9M→$375.2M

Cash position surged 63.2% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
+31.2%
$206.6M→$271.1M

Operating cash flow surged 31.2% — exceptional cash generation, highest quality earnings signal.

Current Assets
Balance Sheet
+19.4%
$639.6M→$763.5M

Current assets grew 19.4% — improving short-term liquidity or inventory/receivables build.

Stockholders Equity
Balance Sheet
+13.2%
$764.9M→$865.9M

Equity base grew 13.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Accounts Receivable
Balance Sheet
-11.7%
$260.0M→$229.7M

Receivables declined — improved collection efficiency or conservative revenue recognition.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-20
ADDED
At December 31, 2025, our national network comprised approximately 2,295 affiliated physicians, including 1,350 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units ( NICUs ), to babies born prematurely or with medical complications.
In 2025, we screened over 793,000 babies for potential hearing loss at 340 hospitals across the nation.
Clinical Research, Education, Quality and Safety As part of our ongoing commitment to improving patient care through evidence-based medicine, we also conduct clinical research, monitor clinical outcomes and implement clinical quality initiatives with a view to improving patient outcomes, shortening the length of hospital stays and reducing long-term health system costs with a focus on women's and children's services that we believe is unrivaled.
Our physician-led approach to clinical research and continuous quality improvement has consistently demonstrated improvements in clinical outcomes, while reducing the costs of care associated with complications as well as variability in care processes.
We provide extensive continuing medical and nursing education to our affiliated clinicians in an effort to ensure that they have access to current treatment methodologies, national best practices and evidence-based guidelines and also provide continuing medical education to external clinicians.
+7 more — sign up free →
REMOVED
At December 31, 2024, our national network comprised approximately 2,335 affiliated physicians, including 1,335 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units ( NICUs ), to babies born prematurely or with medical complications.
In 2024, we screened over 805,000 babies for potential hearing loss at 340 hospitals across the nation.
Clinical Research, Education, Quality and Safety As part of our ongoing commitment to improving patient care through evidence-based medicine, we also conduct clinical research, monitor clinical outcomes and implement clinical quality initiatives with a view to improving patient outcomes, shortening the length of hospital stays and reducing long-term health system costs.
Our physician-centric approach to clinical research and continuous quality improvement has demonstrated improvements in clinical outcomes, while reducing the costs of care associated with complications as well as variability in protocols.
We provide extensive continuing medical and nursing education to our affiliated clinicians in an effort to ensure that they have access to current treatment methodologies, national best practices and evidence-based guidelines.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →